Envoy Medical, Inc.
COCH
$1.48
$0.021.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 225.00K | 278.00K | 302.00K | 297.00K | 316.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 225.00K | 278.00K | 302.00K | 297.00K | 316.00K |
| Cost of Revenue | 742.00K | 819.00K | 821.00K | 738.00K | 760.00K |
| Gross Profit | -517.00K | -541.00K | -519.00K | -441.00K | -444.00K |
| SG&A Expenses | 8.56M | 10.15M | 9.49M | 9.63M | 8.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.48M | 21.73M | 20.17M | 19.78M | 18.68M |
| Operating Income | -19.26M | -21.46M | -19.87M | -19.49M | -18.36M |
| Income Before Tax | -20.80M | -21.07M | -13.55M | -22.85M | -29.83M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.80 | -21.07 | -13.55 | -22.85 | -29.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.80M | -21.07M | -13.55M | -22.85M | -29.83M |
| EBIT | -19.26M | -21.46M | -19.87M | -19.49M | -18.36M |
| EBITDA | -19.08M | -21.28M | -19.71M | -19.35M | -18.23M |
| EPS Basic | -1.50 | -1.37 | -0.86 | -1.90 | -2.82 |
| Normalized Basic EPS | -0.69 | -0.68 | -0.69 | -1.39 | -1.42 |
| EPS Diluted | -1.51 | -1.37 | -0.87 | -1.91 | -2.83 |
| Normalized Diluted EPS | -0.69 | -0.68 | -0.68 | -1.37 | -1.41 |
| Average Basic Shares Outstanding | 75.16M | 77.54M | 68.14M | 58.66M | 49.18M |
| Average Diluted Shares Outstanding | 75.16M | 77.54M | 69.14M | 59.66M | 50.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -11.77% | -8.70% | -- | -- | -- |